Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections, today ...

As one of the leading causes of death worldwide, cancer and its many types have cut many lives short -- some of whom were ...

Against the backdrop of great expectations from the forthcoming N54.9 trillion Federal Government Budget 2025, the recent reversal of its scheduled passage on February 13, 2025 by the National ...